Page 2 - நீலம் கடல் பங்குகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நீலம் கடல் பங்குகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நீலம் கடல் பங்குகள் Today - Breaking & Trending Today

Ord Minnett announces several new senior appointments

Ord Minnett
22 January 2021 – Ord Minnett (Ords), a leading Australian wealth management group, incorporating full-service stockbroking, financial planning, funds management and portfolio services, is pleased to announce the appointment of several key appointments to the Institutional Equities Sales & Research and Private Client Research teams.
Key Appointments
Ord Minnett welcomes the following key appointments:
· Michael Gerges as Senior Research Analyst (Healthcare) who joined the Sydney Institutional Research team on 11 January from Blue Ocean Equities where he covered the healthcare sector including pharmacy, pharmaceuticals, IVF clinics and diagnostic imaging among other sub-sectors in health. Michael was a pharmacist having operated a network of stores around the Hunter region. ....

New South Wales , Luke Macnab , Nick Burmester , James Casey , Supun Wijerathna , Sydney Institutional Research , Client Research , It Services , Deutsche Bank , Research Analysts , Research Analyst , Institutional Equities Sales Research , Michael Gerges As Senior Research Analyst Healthcare , Senior Research Analyst , Ord Minnett , Institutional Equities Sales , Private Client Research , Michael Gerges , Blue Ocean Equities , Ashley Cox , Sydney Institutional Equities Sales , Associate Analyst , Senior Research , Nic Burgess , Wealth Management , Institutional Equities ,

Clarity Pharmaceuticals closes $25m capital raising

Share:
SYDNEY, Dec. 15, 2020 /PRNewswire/ Clarity Pharmaceuticals, a clinical stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has completed a capital raising of $25,000,410.
Dr Alan Taylor, Executive Chairman of Clarity Pharmaceuticals, commented, It has been a pivotal year for Clarity with numerous critical milestones achieved in the development of our main products, advancement of our platform, as well as accelerated corporate and strategic activities despite facing an unprecedented global environment.
The money raised will enable us to keep the momentum from 2020 going and provide financial resources to progress the following important initiatives: ....

New South Wales , Alan Taylor , Louise Emmett , Nuclear Medicine , Clarity Pharmaceuticals , Technology Platform , Drug Administration , Prnewswire Clarity Pharmaceuticals , Memorial Sloan Kettering Cancer Center , Executive Chairman , Prof Louise Emmett , Investigational New Drug , Drug Designations , Rare Paediatric Disease Designations , Blue Ocean Equities , புதியது தெற்கு வேல்ஸ் , ஆலன் டெய்லர் , லூயிஸ் எமெட் , அணு மருந்து , தெளிவு மருந்துகள் , தொழில்நுட்பம் நடைமேடை , நினைவகம் ஸ்லோன் கெட்டரிங் புற்றுநோய் மையம் , நிர்வாகி தலைவர் , ப்ரொஃப் லூயிஸ் எமெட் , நீலம் கடல் பங்குகள் ,